Publications

Home / Publications

Law No. 9,478, dated June 8, 1997, establishes for the Brazilian Petroleum Agency (ANP) the attribution of stimulating research in the sector.   In view of this, the agreements between the Agency and the Oil Companies for exploration, development and production of oil and natural gas have Research, Development and Innovation clauses that establish the obligation for […]

Leia mais

With the COVID-19 pandemic getting more and more serious, known drugs are being heavily tested aiming to find a safe and effective treatment. Chloroquine / chloroquine phosphate (Resochin), favilavir / favipiravir (Avigan), lopinavir & ritonavir (Kaletra), rintatolimod (Ampligen), danoprevir, (Ganovo), remdesivir and others are now being studied for use against COVID-19.   Some of these […]

Leia mais

As coronavirus is quickly spreading, Simões IP developed protocols and contingency plans in order to guarantee its operations.   Among other actions, we are monitoring local Governmental and World Health Organization advices. Business travels are restricted. We have also provided our staff with the necessary equipment for home-working.   📨 For additional information, please contact […]

Leia mais

Due to the recent accession to the Madrid Protocol, the Brazilian Trademark Office published Resolution 248/2019 that deals with trademark registration in a multi-class system.   Even though such Resolution came into force last October, petitioning trademarks in a multiclass system would only be made available on March 9. However, on March 3 the PTO […]

Leia mais

Numerous social media posts claim that coronavirus is known for years and there are patents covering the virus and possible vaccines. This confusion is due to the lack of information about virus in general. The term “coronavirus” actually refers to a broad family of virus, which includes the SARS-CoV and MERS-CoV. The recent outbreak of […]

Leia mais

The Brazilian PTO published this week new statistics regarding the results of the backlog combat plan, announced and implemented in 2019.   According to official data, the PTO reduced the average prosecution time for patent applications from 10 to 9.3 years. Areas like biotech and polymers, which had an average prosecution time of 11.14 and […]

Leia mais

Our partner, Daniela Fasoli, will speak about new trends in prosecution of pharma patent applications in Brazil.   With a population of more than 200 million people and being the 6th largest pharmaceutical market in the world, Brazil is a top priority for patent investments in the pharma industry. Applicants, however, face several obstacles when prosecuting in […]

Leia mais

Brazil, as many other countries, is currently debating the use of cannabis-derived products. On the Regulatory side, the board of ANVISA (the Brazilian Food and Drug Administration) is analyzing proposals for regulation of medicinal cannabis in Brazil. More especially, two drafts of Resolutions (RDCs) are the focus of discussions: one addresses the technical and administrative […]

Leia mais

  In 2016, the Brazilian Health Regulatory Agency (ANVISA) became a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The ICH brings together regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of drug registration. This measure favors the growth of the national pharmaceutical market and the harmonization of […]

Leia mais